30 September 2021 - A new drug that promises to change the lives of thousands of Australians living with multiple sclerosis has been added to the PBS.
Listing of the drug, known as Kesimpta, is expected to save a multiple sclerosis patient up to $28,000 a year and is the only B-cell therapy that can be self-administered at home instead of through a transfusion.